Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma

2.

According to new studies, some cancer patients can safely forego radiation therapy.

3.

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

4.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

5.

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot